methadone has been researched along with dextrorphan in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (72.73) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Terenius, L | 1 |
Chen, RC; Ho, AK; Ho, CC | 1 |
Jhamandas, K; Moffat, JA | 1 |
Chen, RC; Ho, AK | 1 |
Hron, V; Jhamandas, K; Sutak, M | 1 |
Frank, GB; Kokate, TG | 1 |
Frank, GB; Shetty, SS | 1 |
Bowman, ER; Brase, DA; Dewey, WL; Kachur, JF; Martin, BR; Rosemond, R; Welch, S | 1 |
Burwell, B; Lau, C; Slotkin, TA | 1 |
Bochner, F; Kerry, NL; Mikus, G; Somogyi, AA | 1 |
Iqbal, MZ; Lagundoye, O; Lennard, MS; Rostami-Hodjegan, A; Seivewright, N; Shiran, MR; Tucker, GT | 1 |
11 other study(ies) available for methadone and dextrorphan
Article | Year |
---|---|
Opioid peptides and opiates differ in receptor selectivity.
Topics: Animals; Brain; Dextrorphan; Endorphins; Enkephalins; Isomerism; Levorphanol; Methadone; Morphine; Naloxone; Naltrexone; Rats; Receptors, Opioid | 1977 |
Interaction toxicity between ethanol and narcotics in mice with reference to alpha-1-acetylmethadol (LAAM).
Topics: Animals; Brain; Dextrorphan; Drug Interactions; Ethanol; Lethal Dose 50; Levorphanol; Male; Methadone; Methadyl Acetate; Mice; Morphine; Narcotics | 1978 |
Effects of acute and chronic methadone treatment of the uptake of 3H-5-hydroxytryptamine in rat hypothalamus slices.
Topics: Animals; Dextrorphan; Female; Heroin; Humans; Hypothalamus; In Vitro Techniques; Levorphanol; Methadone; Morphine; Naloxone; Rats; Serotonin; Substance Withdrawal Syndrome; Time Factors | 1976 |
Interactions of narcotics, narcotic antagonists, and ethanol during acute, chronic, and withdrawal states.
Topics: Alcohol Drinking; Animals; Animals, Newborn; Dextrorphan; Drug Interactions; Ethanol; Humans; Levorphanol; Male; Methadone; Methadyl Acetate; Mice; Mice, Inbred C57BL; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1976 |
Comparative effects of opiate agonists methadone, levorphanol, and their isomers on the release of cortical ACh in vivo and in vitro.
Topics: Acetylcholine; Adrenal Cortex; Adrenal Glands; Animals; Dextrorphan; In Vitro Techniques; Levorphanol; Methadone; Naloxone; Rats; Stereoisomerism; Time Factors | 1975 |
Blockade of high K+ contractures and Ca(+)+-dependent slow action potentials in frog skeletal muscle by opioid drugs.
Topics: Action Potentials; Animals; Calcium; Dextrorphan; Endorphins; In Vitro Techniques; Levorphanol; Methadone; Morphine; Muscle Contraction; Muscles; Narcotics; Potassium; Rana pipiens | 1990 |
Mechanism for the opioid-induced twitch potentiations of frog's skeletal muscle.
Topics: Animals; Calcium; Dextrorphan; Etorphine; In Vitro Techniques; Meperidine; Methadone; Morphine; Muscle Contraction; Muscles; Narcotics; Rana pipiens; Stimulation, Chemical | 1986 |
Comparison of the ability of opioid analgesics to increase endogenous opioid-like activity in the cerebrospinal fluid of rabbits.
Topics: Animals; Biological Assay; Dextrorphan; Diazepam; Dose-Response Relationship, Drug; Endorphins; Injections, Intraventricular; Injections, Subcutaneous; Levorphanol; Male; Meperidine; Methadone; Nociceptors; Pentazocine; Pentobarbital; Proadifen; Rabbits; Time Factors | 1985 |
An intracellular opiate receptor.
Topics: Adrenal Medulla; Animals; Catecholamines; Chromaffin Granules; Chromaffin System; Dextrorphan; Female; Methadone; Naloxone; Rats; Receptors, Opioid | 1980 |
The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes.
Topics: Autoantibodies; Binding, Competitive; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Dextromethorphan; Dextropropoxyphene; Dextrorphan; Humans; In Vitro Techniques; Methadone; Methylation; Microsomes, Liver; Mixed Function Oxygenases; Oxidation-Reduction; Perhexiline; Phenotype; Quinidine | 1994 |
Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Biomarkers; Caffeine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Dextromethorphan; Dextrorphan; Female; Humans; Isomerism; Male; Methadone; Midazolam; Middle Aged; Narcotics; Opioid-Related Disorders; Saliva; Young Adult | 2009 |